AKT (Phospho-Y315) Polyklonaler Kaninchen-Antikörper

Hauptmerkmale und Details

Polyklonaler Kaninchen-Antikörper gegen AKT (Phospho-Y315)
  • Ziel: AKT (Phospho-Y315)
  • Quelle/Host: Kaninchen
  • Reaktivität: Mensch, Maus, Ratte, Rind, Huhn, Zebrafisch
  • Klonalität: Polyklonal
  • Anwendungen: WB, IHC, IF/ICC
  • Konjugation: Unkonjugiert
  • Lagerung: bei -20°C
  • Marke:
KAT.-NR. : APA06636
US$ Bitte wählen
US$ Bitte wählen
Größe:
Trail-, Großformat- oder Sonderwünsche Bitte kontaktieren Sie uns
Produktdetails
Hintergrund
AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis . This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates . Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported . AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface .
Bewerbung
To ensure optimal assay performance, AREX recommends conducting reagent titration tailored to each testing system for optimal detection results.

WB

1:500 - 1:1000

IHC

1:100 - 1:200

IF/ICC

1:100 - 1:500

*Ergebnisse sind probenspezifisch. Bitte beziehen Sie sich als Referenz auf Ihre lokalen Testbedingungen und Testparameter.
Übersicht

Beschreibung

Polyklonaler Kaninchen-Antikörper gegen AKT (Phospho-Y315)

Spezifität

Erkennt endogene Mengen an AKT-Protein nur, wenn es an Y315 phosphoryliert ist.

Antikörpertyp

Primärer Antikörper

Immunogen

KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding Y315 of human AKT protein. The exact sequence is proprietary.

Reinigung

Der Antikörper wurde durch Immunogenaffinitätschromatographie gereinigt.

Molekulargewicht

Voraussichtlich: 55 kD; Beobachtet: 60 kD

Form/Puffer

Flüssigkeit aus 0,42 % Kaliumphosphat, 0,87 % Natriumchlorid, pH 7,3, 30 % Glycerin und 0,01 % Natriumazid.

Alternative Namen

AKT1; PKB; RAC; RAC-alpha serine/threonine-protein kinase; Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha; AKT2; RAC-beta serine/threonine-protein kinase; Protein kinase Akt-2; Protein kinase B beta; PKB beta; RAC-PK-beta; AKT3; PKBG; RAC-gamma serine/threonine-protein kinase; Protein kinase Akt-3; Protein kinase B gamma; PKB gamma; RAC-PK-gamma; STK-2

Gensymbol

AKT1; AKT2; AKT3

Entrez Gene

207; 208; 10000 (Mensch); 11651; 11652; 23797(Maus); 24185; 25233; 29414(Ratte)

SwissProt

P31749; P31751; Q9Y243 (Mensch); P31750; Q60823; Q9WUA6(Maus); P47196; P47197; Q63484(Ratte)

*AREX continuously optimizes our products. Webpage content may not reflect the latest updates. For inquiries, please contact info@arexbio.com or your local distributor.
*Klonnummer, Reaktivität, Quelle/Host und Klonalität finden Sie oben im Abschnitt Produktname und Hauptfunktionen.
Daten

Western blot analysis of AKT (Phospho-Y315) expression in U87MG (A) whole cell lysates. (Predicted band size: 55 kD; Observed band size: 60 kD)

Immunohistochemical analysis of AKT (Phospho-Y315) staining in human brain formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

Immunofluorescent analysis of AKT (Phospho-Y315) staining in A549 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark.

Direct ELISA antibody dose-response curve using Anti-AKT (Phospho-Y315) Antibody. Antigen (Phosphopeptide and non-phosphopeptide) concentration is 5 ug/ml. Goat Anti-Rabbit IgG (H&L) - HRP was used as the secondary antibody, and signal was developed by TMB substrate.

Lagerung
Kurzfristig bei 4°C lagern. Bei längerer Lagerung bei -20 °C lagern und Einfrier-/Auftauzyklen vermeiden.
Hinweis
Nur für Forschungszwecke. Nicht für diagnostische, therapeutische, prophylaktische oder in vivo-Anwendungen.
FAQs
Was sind die wichtigsten Arten von Forschungsantikörpern und wie unterscheiden sie sich?
Research antibodies are mainly divided into monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies typically offer higher specificity and better batch-to-batch consistency, while polyclonal antibodies often provide stronger affinity but may show more variation between batches. The choice depends on your specific experimental needs.
Wie kann ich feststellen, ob ein Forschungsantikörper für mein Experiment geeignet ist?
It is recommended to carefully review the product datasheet for validated applications, species reactivity, recommended dilutions, and published references. For new antibodies, performing a small-scale validation with positive control samples is usually helpful.
Kann eine unsachgemäße Lagerung von Forschungsantikörpern die Versuchsergebnisse beeinflussen?
Yes. Antibodies are sensitive to temperature, repeated freeze-thaw cycles, and contamination. Improper storage may lead to reduced activity, increased background, or weaker signals. It is best to follow the storage instructions provided in the product datasheet.
Warum funktioniert die im Datenblatt empfohlene Verdünnung in meinem Experiment nicht?
The recommended dilution is based on the supplier’s test conditions. Factors such as sample type, fixation method, and detection system in your lab can influence the optimal working concentration. Performing a dilution series optimization in your own system is often necessary.
Welche Vorsichtsmaßnahmen sollte ich treffen, wenn ich einen neu erworbenen Forschungsantikörper zum ersten Mal verwende?
It is advisable to briefly centrifuge the antibody (especially concentrated or lyophilized ones), then perform a small-scale pilot experiment using the recommended conditions. Recording the batch number and usage date is also helpful for future tracking.
Neue Produkte
Nehmen Sie Kontakt mit AREX auf
Name:*
Tel/Telefon:*
Firma:*
E-Mail:*
Anfrage:
Captcha*
Submitting your email information means that you are willing to receive email information from AREX regarding technology, applications, products, and events. By clicking on the 'unsubscribe' button in the email or by contacting info@arexbio.com You can unsubscribe at any time by sending an email. Regarding your data usage information, please refer to ourDatenschutzrichtlinie.
© AREX 2024. Alle Rechte vorbehalten. Sitemap
4.783221s